A CLINICAL TRIAL TO STUDY THE EFFECT OF SIDDHA DRUG PAVALA VEERA CHUNNAM IN PATIENTS HAVING CHOLELITHIASIS
Phase 2
Not yet recruiting
- Conditions
- Other cholelithiasis,
- Registration Number
- CTRI/2020/09/027900
- Lead Sponsor
- Government Siddha Medical College Chennai
- Brief Summary
This is Phase II Non -Randomized open Clinical Trial to study the safety and efficacy of siddha drug PAVALAVEERA CHUNNAM. The drug is given 65mg twice a day for 48 days. clinical trial is conducted after conducting preclinical studies. The Siddha Drug is mentioned in THE PHARMACOPOEIA OF SIDDHA RESEARCH MEDICINES . During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analyzed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Accidentally identified gall stone in USG Asymptomatic Cholelithiasis.
- Stone Size less than 8mm (normal lumen size is 8mm).
Exclusion Criteria
- Pregnant and lactating mothers.
- Cholecystitis.
- Pancreatitis Obstructive Jaundice.
- Choledo Cholelithiasis Acute Cholelithiasis Gall Stone patients with other comorbidities Malignancy of gall bladder -Will be excluded clinically or based on available medical reports.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome is mainly assessed by reduction in clinical symptoms measured by reduction in size of gall stones with interpretation of USG abdomen. 48days.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Arignar Anna Government Hospital for Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Arignar Anna Government Hospital for Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Nikil Niva JPrincipal investigator07200333774nikilniva@gmail.com